SMAD4-deficient GC cells exhibited the expansion of CD133+ cancer stem cells, along with the inhibition of dendritic cell (DC) differentiation and the aggregation of cytotoxic T cells with granulocyte myeloid-derived suppressor cells (G-MDSC) via CXCL1-containing secretomes. This evidence concerns the gene SMAD4 and cancer.